Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB

Author: Kato Yoshiro   Kamiya Hideki   Koide Naoki   Odkhuu Erdenezaya   Komatsu Takayuki   Dagvadorj Jargalsaikhan   Watarai Atsuko   Kondo Masaki   Kato Koichi   Nakamura Jiro   Yokochi Takashi  

Publisher: Informa Healthcare

ISSN: 0892-3973

Source: Immunopharmacology and Immunotoxicology, Vol.36, Iss.3, 2014-06, pp. : 237-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content